P300 and ATF-2 Are Components of the DRF Complex, Which Regulates Retinoic Acid- and E1A-mediated Transcription of the C-jun Gene in F9 Cells
Overview
Affiliations
Transcriptional activation of the c-jun gene is a critical event in the differentiation of F9 cells. In our previous studies we characterized an element [differentiation response element (DRE)] in the c-jun promoter that is both necessary and sufficient to confer the capacity for differentiation-dependent up-regulation. This element binds the differentiation regulatory factor (DRF) complex, of which one component is the adenovirus E1A-associated protein p300. We have now identified activation transcription factor-2 (ATF-2) as a DNA-binding subunit of the DRF complex. p300 and ATF-2 interact with each other in vivo and in vitro. The bromodomain and the C/H2 domain of p300 mediate the binding to ATF-2, which in turn requires a proline-rich region between amino acids 112 and 350 for its interaction with p300. The phosphorylation of the serine residue at position 121 of ATF-2 appears to be induced by protein kinase C alpha (PKC alpha) after treatment of cells with retinoic acid (RA) or induction with E1A. In cotransfection assays, wild-type ATF-2 enhanced the transcription of an E2/tk-luciferase construct, in conjunction with p300-E2. However, a mutant form of ATF-2 with a mutation at position 121 (pCMVATF-2(Ser121-Ala)) did not. These results suggest that ATF-2 and p300 cooperate in the control of transcription by forming a protein complex that is responsive to differentiation-inducing signals, such as RA or E1A, and moreover, that the phosphorylation of ATF-2 by PKC alpha is probably a signaling event in the pathway that leads to the transactivation of the c-jun gene in F9 cells.
Rooney R Gene. 2020; 754:144882.
PMID: 32535047 PMC: 7394487. DOI: 10.1016/j.gene.2020.144882.
The activating transcription factor 2: an influencer of cancer progression.
Huebner K, Prochazka J, Monteiro A, Mahadevan V, Schneider-Stock R Mutagenesis. 2019; 34(5-6):375-389.
PMID: 31799611 PMC: 6923166. DOI: 10.1093/mutage/gez041.
Wang S, Wuputra K, Liu C, Lin Y, Chen Y, Chai C Oncotarget. 2016; 7(24):36049-36064.
PMID: 27144338 PMC: 5094982. DOI: 10.18632/oncotarget.9102.
AP-1-mediated expression of brain-specific class IVa β-tubulin in P19 embryonal carcinoma cells.
Maruyama Y, Arahara K, Kinoshita E, Arai K J Vet Med Sci. 2015; 76(12):1609-15.
PMID: 25649943 PMC: 4300376. DOI: 10.1292/jvms.14-0343.
Hasegawa H, Ishibashi K, Kubota S, Yamaguchi C, Yuki R, Nakajo H PLoS One. 2014; 9(12):e116048.
PMID: 25545367 PMC: 4278844. DOI: 10.1371/journal.pone.0116048.